Kommentar
Splicing regulation of DNA repair via CCAR1
Molecular Cell · 2024
DOI: 10.1016/j.molcel.2024.06.012 ↗Kurz gefasst
Kommentar in der Zeitschrift Molecular Cell, 2024. Verfasst von Yuxi Ai und 1 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Pharmacology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Hauptthemen laut MEDLINE: DNA Repair, RNA Splicing. Die Arbeit nennt 7 Literaturangaben. Gefördert von: Leukemia & Lymphoma Society, NHLBI, National Cancer Institute.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
DNA RepairRNA SplicingHumansFanconi Anemia Complementation Group A ProteinRNA, MessengerFanconi AnemiaBRCA1 Protein
Substanzen
Fanconi Anemia Complementation Group A ProteinRNA, MessengerBRCA1 Protein
Autor:innen und Institutionen
- Molecular Pharmacology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
- Molecular Pharmacology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Electronic address: abdelwao@mskcc.org.
Förderung
- Leukemia & Lymphoma Society
- NHLBI
- National Cancer Institute
- National Institutes of Health
- Edward P. Evans Foundation
- Merck
- Foundation Medicine
Zitieren
APA
Ai, Y., & Abdel-Wahab, O. (2024). Splicing regulation of DNA repair via CCAR1. Molecular Cell. https://doi.org/10.1016/j.molcel.2024.06.012
Vancouver
Ai Y, Abdel-Wahab O. Splicing regulation of DNA repair via CCAR1. Molecular Cell. 2024. doi:10.1016/j.molcel.2024.06.012
BibTeX
@article{Ai2024,
author = {Ai, Yuxi and Abdel-Wahab, Omar},
title = {Splicing regulation of DNA repair via CCAR1},
journal = {Molecular Cell},
year = {2024},
doi = {10.1016/j.molcel.2024.06.012}
}
EUVIMED